LMNL goes private @$8.50/sh—a 135% premium to the “unaffected” share price on 4/4/23: https://www.prnewswire.com/news-releases/liminal-biosciences-announces-arrangement-agreement-with-structured-alpha-lp-301875390.html The buyer is Structured Alpha LP, who already had a 68% equity stake in LMNL.